NSW-RPRN

UNSW Sydney leads the NSW RNA Production and Research Network (NSW-RPRN), a network funded by the NSW Health Office of Health & Medical Research to:
- Seed the RNA therapeutics R&D ecosystem in NSW and ACT
- Train the future workforce for the RNA therapeutics industry.
The NSW-RPRN consists of three pillars, bringing together development projects and key support capabilities to progress potential RNA therapeutics through pre-clinical trials.



NSW-RPRN Member Organisations
The NSW-RPRN includes several universities and medical research institutions and has built relationships with a number of support organizations located in NSW and the ACT that provide critical infrastructure and expertise for the development of RNA-based therapeutics:
- UNSW
- Macquarie University
- ANU
- Kirby Institute
- Woolcock Institute of Medical Research
- Royal Prince Alfred Hospital
- UNSW Recombinant Products Facility
- Australian Proteome Analysis Facility
- Cell & Molecular Therapies
- Sydney Infectious Diseases Institute
- UTS
- University of Sydney
- Children’s Medical Research Institute
- Westmead Institute of Medical Research
- Children’s Cancer Institute
- Ramaciotti Centre for Genomics
- Centenary Institute
- The ANU Centre for Therapeutic Discovery
- Microbial Genomics Reference Laboratory.
NSW-RPRN Governance
Management committee
- Pall Thordarson – Coordinator, UNSW Sydney
- Scott Cohen – Children’s Medical Research Institute, Westmead
- Daniela Traini – Woolcock Institute
- Richard Payne – University of Sydney
- Christopher Marquis – UNSW Sydney
- Anthony Kelleher – Kirby Institute
- Maria Kavallaris – Children’s Cancer Institute.
External expert advisory committee
- Scott McNeil – University of Basel
- Julie Suman – Next Breath
- Archa Fox – University of Western Australia
- Gary Philips – Pharmaxis
- Phil Kearney – Merck
- John Skerritt – TGA Australia (observer).
Management and administration
UNSW is the lead institution and is the base for management and governance of the NSW-RPRN including activities such as reporting and outreach.
Key Contacts: Joshua Peterson, Catherine McDonald, Marjorie Fox-Owens.